Home LiteratureArticle Details
PMID: 9730896 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.

The Journal of experimental medicine ·Vol. 188 ·No. 5 ·1998-09-07 ·Pages 953-60

Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L, Biassoni R, Moretta A

Abstract

NKp46 has been shown to represent a novel, natural killer (NK) cell-specific surface molecule, involved in human NK cell activation. In this study, we further analyzed the role of NKp46 in natural cytotoxicity against different tumor target cells. We provide direct evidence that NKp46 represents a major activating receptor involved in the recognition and lysis of both human and murine tumor cells. Although NKp46 may cooperate with other activating receptors (including the recently identified NKp44 molecule) in the induction of NK-mediated lysis of human tumor cells, it may represent the only human NK receptor involved in recognition of murine target cells. Molecular cloning of the cDNA encoding the NKp46 molecule revealed a novel member of the immunoglobulin (Ig) superfamily, characterized by two C2-type Ig-like domains in the extracellular portion. The transmembrane region contains the positively charged amino acid Arg, which is possibly involved in stabilizing the association with CD3zeta chain. The cytoplasmic portion, spanning 30 amino acids, does not contain immunoreceptor tyrosine-based activating motifs. Analysis of a panel of human/hamster somatic cell hybrids revealed segregation of the NKp46 gene on human chromosome 19. Assessment of the NKp46 mRNA expression in different tissues and cell types unambiguously confirmed the strict NK cell specificity of the NKp46 molecule. Remarkably, in line with the ability of NKp46 to recognize ligand(s) on murine target cells, the cDNA encoding NKp46 was found to be homologous to a cDNA expressed in murine spleen. In conclusion, this study reports the first characterization of the molecular structure of a NK-specific receptor involved in the mechanism of NK cell activation during natural cytotoxicity.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Blotting, Southern Cattle Cell Line Chromosome Mapping Cloning, Molecular Cytotoxicity, Immunologic/genetics DNA, Complementary/isolation & purification Dogs Humans Immunoglobulins/genetics Killer Cells, Natural/immunology Mice Mice, Inbred BALB C Mice, Inbred C57BL Molecular Sequence Data Multigene Family/immunology Natural Cytotoxicity Triggering Receptor 1 Organ Specificity/genetics Rabbits Rats Receptors, Immunologic/genetics,isolation & purification,physiology Transcription, Genetic/immunology Tumor Cells, Cultured
Chemicals
DNA, Complementary Immunoglobulins NCR1 protein, human Natural Cytotoxicity Triggering Receptor 1 Receptors, Immunologic
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Pessino A
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Italy.
Sivori S
Bottino C
Malaspina A
Morelli L
Moretta L
Biassoni R
Moretta A
References (32)
32 references, click to expand
  1. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.
    Immunity. 1995 May;2(5):439-49 PMID: 7749980
  2. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.
    Science. 1995 Apr 21;268(5209):405-8 PMID: 7716543
  3. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
    J Exp Med. 1995 Sep 1;182(3):875-84 PMID: 7650491
  4. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.
    J Exp Med. 1996 Feb 1;183(2):645-50 PMID: 8627176
  5. Receptors for HLA class-I molecules in human natural killer cells.
    Annu Rev Immunol. 1996;14:619-48 PMID: 8717527
  6. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
    J Exp Med. 1996 Aug 1;184(2):505-18 PMID: 8760804
  7. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.
    Eur J Immunol. 1996 Aug;26(8):1816-24 PMID: 8765026
  8. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes.
    Immunity. 1996 Aug;5(2):163-72 PMID: 8769479
  9. Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase.
    Biochem J. 1995 Jun 15;308 ( Pt 3):801-13 PMID: 8948436
  10. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
    Eur J Immunol. 1997 Feb;27(2):563-7 PMID: 9045931
  11. Natural killer cells: from no receptors to too many.
    Immunity. 1997 Apr;6(4):371-8 PMID: 9133416
  12. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing.
    J Exp Med. 1997 May 19;185(10):1743-51 PMID: 9151699
  13. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells.
    J Immunol. 1997 Jun 1;158(11):5083-6 PMID: 9164921
  14. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
    Eur J Immunol. 1997 May;27(5):1164-9 PMID: 9174606
  15. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors.
    Curr Biol. 1997 Aug 1;7(8):615-8 PMID: 9259559
  16. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor.
    J Immunol. 1997 Sep 1;159(5):2342-9 PMID: 9278324
  17. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes.
    Immunity. 1997 Aug;7(2):283-90 PMID: 9285412
  18. p46, a novel natural killer cell-specific surface molecule that mediates cell activation.
    J Exp Med. 1997 Oct 6;186(7):1129-36 PMID: 9314561
  19. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
    Nature. 1998 Feb 12;391(6668):703-7 PMID: 9490415
  20. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
    Eur J Immunol. 1998 Jan;28(1):327-38 PMID: 9485212
  21. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Nature. 1998 Feb 19;391(6669):795-9 PMID: 9486650
  22. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    J Exp Med. 1998 Mar 2;187(5):813-8 PMID: 9480992
  23. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules.
    J Immunol. 1997 Dec 1;159(11):5192-6 PMID: 9548455
  24. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.
    J Exp Med. 1998 Jun 15;187(12):2065-72 PMID: 9625766
  25. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
    Anal Biochem. 1983 Jul 1;132(1):6-13 PMID: 6312838
  26. CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene.
    J Immunol. 1988 Mar 1;140(5):1685-9 PMID: 2894394
  27. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
    J Exp Med. 1990 Mar 1;171(3):695-714 PMID: 2137855
  28. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    J Exp Med. 1990 Dec 1;172(6):1589-98 PMID: 2147946
  29. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    J Exp Med. 1991 Dec 1;174(6):1393-8 PMID: 1720808
  30. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
    J Exp Med. 1993 Aug 1;178(2):597-604 PMID: 8340759
  31. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
    J Exp Med. 1994 Aug 1;180(2):537-43 PMID: 8046332
  32. The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion.
    J Cell Biol. 1995 Jun;129(6):1677-89 PMID: 7790363
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1998-09-07
Pages
953-60
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC3207313
Subset
IM
Databases
GENBANK
AJ001383, AJ006121, AJ006122, AJ006123
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]